# Transdermal Administration by a Novel Wireless Iontophoresis Device

> **NCT06351852** · EARLY_PHASE1 · COMPLETED · sponsor: **James J. Peters Veterans Affairs Medical Center** · enrollment: 2 (actual)

## Conditions studied

- Spinal Cord Injuries
- Constipation
- Fecal Incontinence
- Neurogenic Bowel

## Interventions

- **DRUG:** Combination of Neostigmine and Glycopyrrolate
- **DEVICE:** I-Box by Dynatronics

## Key facts

- **NCT ID:** NCT06351852
- **Lead sponsor:** James J. Peters Veterans Affairs Medical Center
- **Sponsor class:** FED
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-22
- **Primary completion:** 2024-09-24
- **Final completion:** 2024-09-24
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2025-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06351852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06351852, "Transdermal Administration by a Novel Wireless Iontophoresis Device". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06351852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
